This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Tale of the Tape: Archive
Deere (DE) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Deere (DE) closed at $487.24 in the latest trading session, marking a +2.29% move from the prior day.
DEPositive Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Bank of America (BAC) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Bank of America (BAC) settling at $51.56, representing a +1.1% change from its previous close.
BACPositive Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
UnitedHealth Group (UNH) concluded the recent trading session at $319.97, signifying a +2.71% move from its prior day's close.
UNHPositive Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
3 Reasons Growth Investors Will Love Flowserve (FLS)
by Zacks Equity Research
Flowserve (FLS) could produce exceptional returns because of its solid growth attributes.
FLSPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
by Zacks Equity Research
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
IDXXPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Ensign Group (ENSG) is a Solid Choice
by Zacks Equity Research
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
ENSGPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Commercial Metals (CMC)
by Zacks Equity Research
Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CMCPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Interface (TILE)
by Zacks Equity Research
Interface (TILE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
TILEPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Tencent (TCEHY)
by Zacks Equity Research
Tencent (TCEHY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
TCEHYPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Federal Signal (FSS) Now
by Zacks Equity Research
Federal Signal (FSS) possesses solid growth attributes, which could help it handily outperform the market.
FSSPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy CSW Industrials (CSW) Now
by Zacks Equity Research
CSW Industrials (CSW) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CSWPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Can GigaCloud Technology Inc. (GCT) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
GigaCloud Technology Inc. (GCT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
GCTPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Merit Medical (MMSI) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Merit Medical (MMSI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MMSIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Research Solutions (RSSS) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Research Solutions (RSSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
RSSSPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Bilibili (BILI) Rating Upgrade to Buy
by Zacks Equity Research
Bilibili (BILI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BILIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why
by Zacks Equity Research
Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EKSOPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BSXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
National Health Investors (NHI) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
National Health Investors (NHI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NHIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About American Express (AXP) Rating Upgrade to Buy
by Zacks Equity Research
American Express (AXP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AXPPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CenterPoint (CNP) Upgraded to Buy: Here's Why
by Zacks Equity Research
CenterPoint (CNP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CNPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Universal Insurance Holdings (UVE) Is Up 2.35% in One Week: What You Should Know
by Zacks Equity Research
Does Universal Insurance Holdings (UVE) have what it takes to be a top stock pick for momentum investors? Let's find out.
UVEPositive Net Change
momentum-investor momentum-stocks price-change volume
What Makes ITT (ITT) a New Buy Stock
by Zacks Equity Research
ITT (ITT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ITTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Crown (CCK) Upgraded to Buy: Here's Why
by Zacks Equity Research
Crown (CCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CCKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
This is Why WaFd (WAFD) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does WaFd (WAFD) have what it takes? Let's find out.
WAFDPositive Net Change
dividend dividend-stocks dividend-yield high-growth income-investor
AYI or AMPL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AYI vs. AMPL: Which Stock Is the Better Value Option?
AYIPositive Net Change AMPLPositive Net Change
value-stocks which-stock-is-cheaper